Advanced Medicine

Originally founded as Advanced Medicine in 1996, the company was renamed Theravance in 2002 and later split into two independent entities: Theravance Biopharma and Innoviva. The company is a pioneer in the application of multivalent drug design to small molecule therapeutics, focusing on the discovery and development of medicines for respiratory disease, gastrointestinal disorders, and infectious diseases. Its most notable successes include the development of several blockbuster respiratory treatments in collaboration with GSK, such as Breo Ellipta and Anoro Ellipta. Today, the legacy of Advanced Medicine continues through Theravance Biopharma's focus on organ-selective medicines and Innoviva's management of the respiratory royalty portfolio.